The findings of this study reveal that most patients (90%) presented intermediate CIN, with values ranging between 33% and 49%, while only 1 (10%) patient (ER+/PR+/HER2+) presented high CIN (52%) (Figure 1 and Figure 2 and Supplementary Table S1). This evidence concerns the gene ERBB2 and cervical squamous intraepithelial neoplasia.